Assessing preferences for improved smoking cessation medications: a discrete choice experiment

Abstract

Background The use of smoking cessation medications can considerably enhance the long-term abstinence rate at a reasonable cost, but only a small proportion of quitters seek medical assistance. The objective of this study was to evaluate the factors that influence the decision to use such treatments and the willingness-to-pay of smokers for improved cessation drugs. Method A discrete choice experiment was conducted amongst smokers in the French-speaking part of Switzerland. Choice sets consisted of two hypothetical medications described via five attributes (price, efficacy, possibility of minor side effects, attenuation of weight gain and availability) and an opt-out option. Various discrete choice models were estimated to analyse both the factors that influence treatment choice and those that influence the overall propensity to use a smoking cessation medication. Results Our results indicate that smokers are willing to pay for higher efficacy, less-frequent side effects and prevention of weight gain. Whether the drug is available overthe-counter or on medical prescription is of secondary importance. In addition, we show that there are several individual-specific factors influencing the decision to use such medications, including education level. Results also indicate substantial preference heterogeneity. Conclusion This study shows that there is a potential demand for improved cessation medications. Broader usage could be reached through lower out-of-pocket price and greater efficacy. Secondary aspects such as side effects and weight gain should also be taken into consideration.

The impact of flavour, device type and warning messages on youth preferences for electronic nicotine delivery systems: evidence from an online discrete choice experiment

“…In other words, this method models decision trees with two branches, with one branch leading to opting out and the other leading to the use or uptake of a hypothetical product (see figures 1 and 2). 52 Because never-users have not initiated ENDS use, their decision-making is more likely to follow this format, which is the rationale for estimating a nested logit model for never-users.…”

“…Standard errors were clustered at the individual level to take account of the correlation among choices made by the same participant. It is also worth noting that both the conditional and nested logit models intrinsically assume independence of irrelevant alternatives (IIA) that the relative probability of choosing A over B is independent of an additional item C 52. We conducted Hausman and McFadden and likelihood-ratio tests to test this assumption.…”

To “Vape” or Smoke? Experimental Evidence on Adult Smokers

“…We conduct a discrete choice experiment (DCE) in a sample of adult tobacco cigarette smokers to help address these information gaps. DCE, a stated preference technique, is increasingly employed by economists to study tobacco‐related products (Buckell, Marti, and Sindelar ; Czoli et al ; Ida and Goto ; Kenkel et al ; Marti , ; Pesko et al ; Regmi et al ; Shang et al ). These methods are grounded in consumer choice theory established by Lancaster ().…”

Valuing Morbidity in Environmental Benefit-Cost Analysis

“…Li et al (2012) measure WTP for a hypothetical new treatment that cures prostate cancer without side effects. Marti (2012) and Servan-Mori et al (2012) use discrete-choice experiments to measure WTP for smoking cessation medications. Smoking cessation is generally sought as a means to reduce the subject's own health risks, so these values may transfer, to some extent, to private demands for environmental respiratory health risk reductions.…”